If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Issue of Equity - Correction

29 Nov 2017 16:40

RNS Number : 8982X
CATCo Reinsurance Opps Fund Ltd
29 November 2017
 

THIS RELEASE REPLACES NO. 7652X WHICH WAS ANNOUNCED YESTERDAY.

The number of Ordinary shares was incorrectly reported.

All other details remain unchanged.

 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL OR TO U.S. PERSONS.

 

CATCo Reinsurance Opportunities Fund Ltd.

 

Result of Equity Issue

 

To: Specialist Fund Segment, London Stock Exchange and Bermuda Stock Exchange

Date: 28 November 2017

 

Following its announcement on 8 November 2017, the Company is pleased to announce that it has received applications and commitments for a total of 543,000,000 new C Shares pursuant to the Initial Placing and Offer at the price of US$1 per share, raising gross proceeds of US$543,000,000. Accordingly applications under the Offer and commitments under the Initial Placing will all be met in full. The Company received commitments for a total of 528,845,098 C Shares through the Initial Placing and applications for a total of 14,154,902 C Shares through the Offer.

 

Application has been made for 543,000,000 C Shares to be issued pursuant to the Initial Placing and Offer to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange. It is expected that Admission will become effective, and dealings will commence, at 8:00am (London time) on 1 December 2017.

 

Following Admission, the number of Ordinary Shares that the Company has in issue will be 391,666,430 and the number of C Shares that the Company has in issue will be 543,000,000. The C Shares carry the right to attend or vote at any general meeting of the Company in the same manner as the Ordinary Shares. Accordingly, the total number of voting rights in the Company will be 934,666,430 and the figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

The Company will instruct Euroclear on or around 1 December 2017 (or as soon as practicable thereafter) to credit the appropriate stock accounts in CREST of the placees and subscribers (on a delivery versus payment basis) with their respective entitlements to Depositary Interests in respect of C Shares. Temporary documents of title will not be issued pending the dispatch by post of definitive certificates for C Shares in certificated form, which is expected to take place in the week commencing 11 December 2017.

 

Tony Belisle, Chief Executive, Markel CATCo Investment Management Ltd., said:

 

"We are delighted with the tremendous support shown by existing and new investors for Markel CATCo's specialised ILS investment opportunity. The fundraise will ensure the Company continues to meet the growing demand from our buyers for our unique reinsurance protections."

 

For further information, please contact:

 

Judith Wynne, General Counsel

Mobile: +44 (0) 7986 205364

Telephone: +1 (441) 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way, Chief Operating Officer

Mobile: +1 (441) 504 9178

Telephone: +1 (441) 493 900

Email: mark.way@markelcatco.com

  

Numis Securities Limited

Hugh Jonathan / Harry Trueman

Telephone: +44 (0) 20 7260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGGAWGUPMGQB
Date   Source Headline
2nd Mar 20164:20 pmRNSPublication of Supplementary Prospectus
2nd Mar 20162:44 pmRNSDirector/PDMR Shareholding
29th Feb 20168:46 amRNSNet Asset Value(s)
22nd Feb 20167:00 amRNSAnnual Financial Report 2015
19th Feb 20163:51 pmRNSDoc re. Disclosure of Home Member State
16th Feb 20167:00 amRNSDirectorate Change
29th Jan 20167:00 amRNSDividend Declaration and Update C Share Conversion
25th Jan 20167:00 amRNSPortfolio Update
21st Jan 20167:00 amRNSNet Asset Value(s)
18th Dec 201512:44 pmRNSPublication of Supplementary Prospectus
16th Dec 20151:50 pmRNSNet Asset Value(s)
16th Dec 20157:00 amRNSNet Asset Value(s)
9th Dec 20157:00 amRNSStatement re Investment Manager
7th Dec 20154:05 pmRNSIssue of Equity
12th Nov 20159:21 amRNSNet Asset Value(s) & Return of Value Tender Offer
4th Nov 20153:13 pmRNSHolding(s) in Company
3rd Nov 20155:23 pmRNSHolding(s) in Company
2nd Nov 20153:32 pmRNSHolding(s) in Company
29th Oct 20157:00 amRNSResult of Equity Issue and SGM results
16th Oct 20153:58 pmRNSNet Asset Value(s)
2nd Oct 20154:28 pmRNSHolding(s) in Company
29th Sep 20155:02 pmRNSPublication of Prospectus
21st Sep 20157:00 amRNSIssue of Equity
16th Sep 201512:35 pmRNSNet Asset Value(s)
10th Sep 20157:00 amRNSAcquisition
14th Aug 201512:27 pmRNSHalf Yearly Report
14th Aug 20157:00 amRNSNet Asset Value(s)
10th Jul 20157:00 amRNSNet Asset Value(s)
17th Jun 20157:00 amRNSNet Asset Value(s)
15th May 20159:02 amRNSNet Asset Value(s)
7th May 20157:00 amRNSHolding(s) in Company
23rd Apr 20152:47 pmRNSHolding(s) in Company
22nd Apr 20152:50 pmRNSHolding(s) in Company
15th Apr 20157:00 amRNSNet Asset Value(s)
24th Mar 20153:07 pmRNSHolding(s) in Company
24th Mar 201512:37 pmRNSResult of AGM
13th Mar 20157:00 amRNSNet Asset Value(s)
26th Feb 20157:01 amRNSHolding(s) in Company
23rd Feb 20157:00 amRNSNet Asset Value(s)
18th Feb 20152:33 pmRNSDirector/PDMR Shareholding
17th Feb 20153:10 pmRNSAnnual Financial Report
9th Feb 20157:00 amRNSDirectorate Change
29th Jan 20152:30 pmRNSResult of SGM
15th Jan 20157:00 amRNSPortfolio Update
14th Jan 20157:00 amRNSNet Asset Value(s)
5th Jan 20157:00 amRNSDividend Declaration
5th Jan 20157:00 amRNSProposed Return of Value to Shareholders
12th Dec 20147:00 amRNSNet Asset Value(s)
12th Dec 20147:00 amRNSDirectorate Change
11th Nov 20144:47 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.